Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19.
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Volpi S.;Gattorno M.;Ravelli A.;
2020-01-01
Abstract
Poor outcomes in COVID-19 correlate with clinical and laboratory features of cytokine storm syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy may prevent immunopathology and could help conserve limited health care resources. While studies are ongoing, extrapolating from clinical experience in cytokine storm syndromes may benefit the multidisciplinary teams caring for patients with severe COVID-19.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020_OntheAlertforCytokie.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
353.81 kB
Formato
Adobe PDF
|
353.81 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
